← Back to Search

Excimer Laser

Excimer Laser Trabeculostomy for Glaucoma (ELTGTS Trial)

Waitlist Available
Research Sponsored by ELT Sight, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medicated IOP of <=24 mmHg
At least 45 years old
Screening 3 weeks
Treatment Varies
Follow Up 24 month
Awards & highlights

ELTGTS Trial Summary

This trial will test a new procedure to lower eye pressure in people with early to moderate stage primary open-angle glaucoma who are also having cataract surgery.

Who is the study for?
Adults over 45 with mild to moderate primary open-angle glaucoma and cataracts can join this trial. They must have specific intraocular pressure levels, a certain angle in their eye's drainage area, and no past major eye surgeries. Pregnant or nursing women and those not using birth control are excluded.Check my eligibility
What is being tested?
The ELIOS System procedure is being tested for its ability to lower the pressure inside the eye when combined with cataract surgery in adults with open-angle glaucoma. The study aims to assess both safety and effectiveness of this treatment.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site of operation, temporary visual disturbances, increased eye pressure post-surgery, inflammation or infection risks associated with any surgical intervention.

ELTGTS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
My eye pressure is 24 mmHg or less with medication.
I am at least 45 years old.
I have a cataract that can be operated on, and my vision is 20/40 or worse.
I have been diagnosed with mild to moderate open-angle glaucoma.

ELTGTS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of subjects who achieve a decrease in medication-free mean diurnal IOP (DIOP) from baseline of at least 20%
Secondary outcome measures
Mean Change in medication-free DIOP from baseline

ELTGTS Trial Design

1Treatment groups
Experimental Treatment
Group I: ELIOS ProcedureExperimental Treatment1 Intervention
ELIOS Procedure

Find a Location

Who is running the clinical trial?

ELT Sight, IncLead Sponsor
Elios Vision, Inc.Lead Sponsor
2 Previous Clinical Trials
259 Total Patients Enrolled
2 Trials studying Glaucoma
259 Patients Enrolled for Glaucoma
Iqbal (Ike) Ahmed, MDStudy DirectorPrism Eye Institute
1 Previous Clinical Trials
65 Total Patients Enrolled
1 Trials studying Glaucoma
65 Patients Enrolled for Glaucoma

Media Library

ELIOS Procedure (Excimer Laser) Clinical Trial Eligibility Overview. Trial Name: NCT04899063 — N/A
Glaucoma Research Study Groups: ELIOS Procedure
Glaucoma Clinical Trial 2023: ELIOS Procedure Highlights & Side Effects. Trial Name: NCT04899063 — N/A
ELIOS Procedure (Excimer Laser) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04899063 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial being administered in multiple locations throughout the US?

"This trial is administered in 20 different sites throughout the country, including Rock Island, DeLand and Largo. To reduce travelling demands associated with participating in this study, we advise selecting a clinical site that's nearest to you."

Answered by AI

Is the current research project actively seeking participants?

"Affirmative. According to the data available on clinicaltrials.gov, this medical trial first went online on May 10th 2021 and was recently updated in September 27th 2022; it is still recruiting patients - 318 participants are needed between 20 sites."

Answered by AI

What is the aggregate amount of participants engaged in this experiment?

"That is accurate. According to records on clinicaltrials.gov, this medical experiment has been actively recruiting since May 10th 2021 and was last modified on September 27 2022. As such, the team needs 318 individuals across 20 different sites for participation in their trial."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Did not meet criteria
~0 spots leftby Jun 2024